电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

PD-L1 抗体 (AA 34-241)

This anti-PD-L1 antibody is a 兔 多克隆 antibody detecting PD-L1 in WB, IHC, IP 和 IF/ICC. Suitable for 小鼠.
产品编号 ABIN2921662
发货至: 中国

Quick Overview for PD-L1 抗体 (AA 34-241) (ABIN2921662)

抗原

See all PD-L1 抗体
PD-L1 (CD274 (PD-L1))

适用

  • 213
  • 120
  • 72
  • 6
  • 6
  • 5
  • 5
  • 1
  • 1
小鼠

宿主

  • 144
  • 93
  • 20
  • 5
  • 4
  • 4
  • 2
  • 1

克隆类型

  • 143
  • 121
  • 7
多克隆

标记

  • 145
  • 20
  • 14
  • 12
  • 9
  • 5
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
This PD-L1 antibody is un-conjugated

应用范围

  • 172
  • 125
  • 83
  • 74
  • 45
  • 44
  • 40
  • 28
  • 23
  • 15
  • 10
  • 7
  • 7
  • 5
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB), Immunohistochemistry (IHC), Immunoprecipitation (IP), Immunofluorescence (fixed cells) (IF/ICC)
  • 抗原表位

    • 29
    • 16
    • 15
    • 14
    • 11
    • 11
    • 10
    • 10
    • 7
    • 7
    • 7
    • 4
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 34-241

    纯化方法

    Antigen-specific affinity chromatography followed by Protein A affinity chromatography

    免疫原

    PDCD1LG1 (Ser34-Val241)
  • 应用备注

    Optimal working dilution should be determined by the investigator.

    限制

    仅限研究用
  • 状态

    Liquid

    浓度

    500 μg/mL

    缓冲液

    PBS,  pH 7.4, containing 0.02 % Sodium azide, 50 % glycerol.

    储存液

    Sodium azide

    注意事项

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    储存条件

    4 °C,-20 °C

    储存方法

    Store at 4 °C for frequent use. Aliquot and store at -20 °C for one year. Avoid repeated freeze/thaw cycles.
  • 抗原

    PD-L1 (CD274 (PD-L1))

    别名

    Programmed Cell Death Protein 1 Ligand 1

    UniProt

    Q9EP73

    途径

    Cancer Immune Checkpoints
You are here:
Chat with us!